Derk P. Allersma

Groningen, GR 9713GZ, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Development of Clinical-Grade Durvalumab-680LT and Nivolumab-800CW for Multispectral Fluorescent Imaging of the PD-1/PD-L1 Axis of the Immune Checkpoint Pathway.

Development of Clinical-Grade Durvalumab-680LT and Nivolumab-800CW for Multispectral Fluorescent Imaging of the PD-1/PD-L1 Axis of the Immune Checkpoint Pathway.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 12, 2025

Optimization of the Production Process of Clinical-Grade Human Salivary Gland Organoid-Derived Cell Therapy for the Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer.

Optimization of the Production Process of Clinical-Grade Human Salivary Gland Organoid-Derived Cell Therapy for the Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer.

Journal: Pharmaceutics

Published: February 15, 2024

Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer.

Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer.

Journal: Pharmaceutics

Published: June 20, 2022

Performance of Tablet Splitters, Crushers, and Grinders in Relation to Personalised Medication with Tablets.

Performance of Tablet Splitters, Crushers, and Grinders in Relation to Personalised Medication with Tablets.

Journal: Pharmaceutics

Published: January 07, 2022

Development and Characterisation of Antibody-Based Optical Imaging Probes for Inflammatory Bowel Disease.

Development and Characterisation of Antibody-Based Optical Imaging Probes for Inflammatory Bowel Disease.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 15, 2021

Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiency.

Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiency.

Journal: Journal of inherited metabolic disease

Published: November 16, 2020

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers.

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 06, 2020

Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency.

Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 19, 2019

GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles.

GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: June 04, 2019

Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW.

Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 25, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026